Home > Investor Relations
Achillion is focused on solutions for the most challenging problems in infectious disease.
The investor pages that follow are your resource for financial information about Achillion Pharmaceuticals. In this section you will find information about our current and historical share price, analyst coverage, SEC filings, an electronic version of our annual report and frequently asked questions as well as forms to request additional information.
Apr 25, 2015
Achillion Presents Detailed Clinical Results on ACH-3102 and ACH-3422 at the International Liver Congress
Apr 8, 2015